154 related articles for article (PubMed ID: 2501812)
21. Specific involvement of striatal D1 and D2 dopamine receptors in the neuroleptic catalepsy in rats.
Wardas J; Pietraszek M; Ossowska K; Wolfarth S
Pol J Pharmacol; 1995; 47(4):349-53. PubMed ID: 8616516
[TBL] [Abstract][Full Text] [Related]
22. Intraaccumbens raclopride attenuates amphetamine-induced locomotion, but fails to prevent the response-reinstating properties of food reinforcement.
Chausmer A; Ettenberg A
Pharmacol Biochem Behav; 1999 Feb; 62(2):299-305. PubMed ID: 9972697
[TBL] [Abstract][Full Text] [Related]
23. Raclopride, but not SCH 23,390, induces maldirected jumping in rats trained to perform a run-climb-run behavioral task.
Senyuz L; Fowler SC
Psychopharmacology (Berl); 1993; 112(4):518-20. PubMed ID: 7871066
[TBL] [Abstract][Full Text] [Related]
24. Effects of dopamine antagonists and accumbens dopamine depletions on time-constrained progressive-ratio performance.
Aberman JE; Ward SJ; Salamone JD
Pharmacol Biochem Behav; 1998 Dec; 61(4):341-8. PubMed ID: 9802826
[TBL] [Abstract][Full Text] [Related]
25. The effects of dopaminergic agonists and antagonists on the frequency-response function for hypothalamic self-stimulation in the rat.
Nakajima S; O'Regan NB
Pharmacol Biochem Behav; 1991 Jun; 39(2):465-8. PubMed ID: 1682950
[TBL] [Abstract][Full Text] [Related]
26. Dopamine receptor antagonists reverse amphetamine-induced behavioral alteration on a differential reinforcement for low-rate (DRL) operant task in the rat.
Cheng RK; Liao RM
Chin J Physiol; 2007 Apr; 50(2):77-88. PubMed ID: 17608145
[TBL] [Abstract][Full Text] [Related]
27. Attenuation of the locomotor-sensitizing effects of the D2 dopamine agonist bromocriptine by either the D1 antagonist SCH 23390 or the D2 antagonist raclopride.
Wise RA; Carlezon WA
Synapse; 1994 Jul; 17(3):155-9. PubMed ID: 7974197
[TBL] [Abstract][Full Text] [Related]
28. Positive and negative interactions in the behavioural expression of D1 and D2 receptor stimulation in a model of Parkinsonism: role of priming.
Morelli M; Fenu S; Cozzolino A; Di Chiara G
Neuroscience; 1991; 42(1):41-8. PubMed ID: 1830642
[TBL] [Abstract][Full Text] [Related]
29. Anticholinergic drugs potentiate dopamine D1 but not D2 antagonists on a conditioned avoidance task in rats.
Iorio LC; Cohen M; Coffin VL
J Pharmacol Exp Ther; 1991 Jul; 258(1):118-23. PubMed ID: 1830098
[TBL] [Abstract][Full Text] [Related]
30. Reward and reinforcement produced by drinking water: role of opioids and dopamine receptor subtypes.
Agmo A; Federman I; Navarro V; Padua M; Velazquez G
Pharmacol Biochem Behav; 1993 Sep; 46(1):183-94. PubMed ID: 8255911
[TBL] [Abstract][Full Text] [Related]
31. Haloperidol, raclopride, and eticlopride induce microcatalepsy during operant performance in rats, but clozapine and SCH 23390 do not.
Fowler SC; Liou JR
Psychopharmacology (Berl); 1998 Nov; 140(1):81-90. PubMed ID: 9862406
[TBL] [Abstract][Full Text] [Related]
32. Bidirectional effects of dopamine D2 receptor antagonists on responding for a conditioned reinforcer.
Smith JK; Neill JC; Costall B
Pharmacol Biochem Behav; 1997 Aug; 57(4):843-9. PubMed ID: 9259014
[TBL] [Abstract][Full Text] [Related]
33. Suppression or facilitation of operant behaviour by raclopride dependent on concentration of sucrose reward.
Phillips G; Willner P; Muscat R
Psychopharmacology (Berl); 1991; 105(2):239-46. PubMed ID: 1839065
[TBL] [Abstract][Full Text] [Related]
34. Attenuation of water intake and operant responding by dopamine D2 antagonists: raclopride provides important cues for understanding the functional mechanism of action.
Ljungberg T
Pharmacol Toxicol; 1989 Jul; 65(1):9-12. PubMed ID: 2780512
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the pharmacological characteristics of [3H]raclopride and [3H]SCH 23390 binding to dopamine receptors in vivo in mouse brain.
Andersen PH
Eur J Pharmacol; 1988 Jan; 146(1):113-20. PubMed ID: 2895008
[TBL] [Abstract][Full Text] [Related]
36. Involvement of D1 dopamine receptors in the nicotine-induced neuro-endocrine effects and depletion of diencephalic catecholamine stores in the male rat.
Andersson K; Fuxe K; Eneroth P; Härfstrand A; Agnati LF
Neuroendocrinology; 1988 Aug; 48(2):188-200. PubMed ID: 2975769
[TBL] [Abstract][Full Text] [Related]
37. Mediation of rat postejaculatory 22 kHz ultrasonic vocalization by dopamine D2 receptors.
Cagiano R; Barfield RJ; White NR; Pleim ET; Cuomo V
Pharmacol Biochem Behav; 1989 Sep; 34(1):53-8. PubMed ID: 2576313
[TBL] [Abstract][Full Text] [Related]
38. Reinforced responding of the 11-day-old rat pup: synergistic interaction of D1 and D2 dopamine receptors.
McDougall SA; Crawford CA; Nonneman AJ
Pharmacol Biochem Behav; 1992 May; 42(1):163-8. PubMed ID: 1388275
[TBL] [Abstract][Full Text] [Related]
39. Effects of spiperone, raclopride, SCH 23390 and clozapine on apomorphine inhibition of sensorimotor gating of the startle response in the rat.
Swerdlow NR; Keith VA; Braff DL; Geyer MA
J Pharmacol Exp Ther; 1991 Feb; 256(2):530-6. PubMed ID: 1825226
[TBL] [Abstract][Full Text] [Related]
40. Acute effects of d-amphetamine on the differential reinforcement of low-rate (DRL) schedule behavior in the rat: comparison with selective dopamine receptor antagonists.
Liao RM; Cheng RK
Chin J Physiol; 2005 Mar; 48(1):41-50. PubMed ID: 15973966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
